FDA以电子健康档案作为真实世界数据的监管考虑
FDA’s Regulatory Considerations for Electronic Health Records as Real-world Data
-
摘要: 电子健康档案作为真实世界数据的重要组成部分,目前广泛用于安全性研究,并逐渐用于有效性研究。本文系统介绍了美国食品药品监督管理局对研究者在临床研究中使用电子健康档案数据作为真实世界数据支持药物监管决策时的相关考虑,以期为中国电子健康档案数据作为真实世界数据在药物研发与注册方面的应用提供参考和借鉴。Abstract: As an important part of real-world data, electronic health record is widely used in safety research and gradually used in effectiveness research. This article systematically introduces the FDA's considerations when researchers use electronic health record as real-world data to support drug regulatory decision-making in clinical research, with a view to providing reference for the application of electronic health record as real-world data in drug development and registration in China.